에스알바이오텍 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이소형, was filed 13 Feb 2026.
에스알바이오텍: what insiders have been doing
에스알바이오텍, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 10 November 2026, brought 1 filing signed by 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,648 companies we follow on the same exchange. The full history, which starts in 2021, counts 11 purchases against 2 sales.
The most recent open-market purchase was published on 13 February 2026, 270 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
· cache
- 897,572 sharesKRXDART:20260213002479Canonical exit: 10 May 2026 (T+90)
- 8,068 sharesShareKRXDART:20250804000183Canonical exit: 2 Nov 2025 (T+90)
- ShareKRXDART:20240701000145
- 244,802 sharesKRXDART:20240701000143
- ShareKRXDART:20240626000094Canonical exit: 22 Sept 2024 (T+90)
- 250,000 sharesKRXDART:20240625000335Canonical exit: 12 Sept 2024 (T+90)
- 290,507 sharesKRXDART:20240620000087Canonical exit: 16 Sept 2024 (T+90)
- 290,507 sharesKRXDART:20221220000140Canonical exit: 20 Mar 2023 (T+90)
- 71,570 sharesKRXDART:20220314000570Canonical exit: 12 Jun 2022 (T+90)
- 71,570 sharesShareKRXDART:20220314000575Canonical exit: 2 Jun 2022 (T+90)
- 290,507 sharesKRXDART:20210720000245Canonical exit: 18 Oct 2021 (T+90)
- 290,507 sharesKRXDART:20210510000461Canonical exit: 8 Aug 2021 (T+90)
- 290,507 sharesKRXDART:20210409002010Canonical exit: 8 Jul 2021 (T+90)
13 of 13 declarations
About 에스알바이오텍
Listed on the XKRX market, SR Biotech specializes in the health and pharmaceutical sector. The company focuses on developing innovative biopharmaceutical solutions.